These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Residual flow signals predict complete recanalization in stroke patients treated with TPA. Labiche LA; Malkoff M; Alexandrov AV J Neuroimaging; 2003 Jan; 13(1):28-33. PubMed ID: 12593128 [TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of blood pressure variability after thrombolysis in acute stroke. Delgado-Mederos R; Ribo M; Rovira A; Rubiera M; Munuera J; Santamarina E; Delgado P; Maisterra O; Alvarez-Sabin J; Molina CA Neurology; 2008 Aug; 71(8):552-8. PubMed ID: 18550860 [TBL] [Abstract][Full Text] [Related]
28. Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography--guided pilot study. Sekoranja L; Loulidi J; Yilmaz H; Lovblad K; Temperli P; Comelli M; Sztajzel RF Stroke; 2006 Jul; 37(7):1805-9. PubMed ID: 16763175 [TBL] [Abstract][Full Text] [Related]
29. Intra-arterial thrombolysis of acute iatrogenic intracranial arterial occlusion attributable to neuroendovascular procedures or coronary angiography. Arnold M; Fischer U; Schroth G; Nedeltchev K; Isenegger J; Remonda L; Windecker S; Brekenfeld C; Mattle HP Stroke; 2008 May; 39(5):1491-5. PubMed ID: 18323478 [TBL] [Abstract][Full Text] [Related]
30. A new therapeutic strategy for acute ischemic stroke: sequential combined intravenous tPA-tenecteplase for proximal middle cerebral artery occlusion based on first results in 13 consecutive patients. Smadja D; Chausson N; Joux J; Saint-Vil M; Signaté A; Edimonana M; Jeannin S; Bartoli B; Aveillan M; Cabre P; Olindo S Stroke; 2011 Jun; 42(6):1644-7. PubMed ID: 21527758 [TBL] [Abstract][Full Text] [Related]
31. Timing of recanalization after microbubble-enhanced intravenous thrombolysis in basilar artery occlusion. Pagola J; Ribo M; Alvarez-Sabín J; Lange M; Rubiera M; Molina CA Stroke; 2007 Nov; 38(11):2931-4. PubMed ID: 17901389 [TBL] [Abstract][Full Text] [Related]
32. Pre-tissue plasminogen activator blood pressure levels and risk of symptomatic intracerebral hemorrhage. Tsivgoulis G; Frey JL; Flaster M; Sharma VK; Lao AY; Hoover SL; Liu W; Stamboulis E; Alexandrov AW; Malkoff MD; Alexandrov AV Stroke; 2009 Nov; 40(11):3631-4. PubMed ID: 19762689 [TBL] [Abstract][Full Text] [Related]
33. Design of a PROspective multi-national CLOTBUST collaboration on reperfusion therapies for stroke (CLOTBUST-PRO). Saqqur M; Tsivgoulis G; Molina CA; Demchuk AM; Garami Z; Barreto A; Spengos K; Forteza A; Mikulik R; Sharma VK; Brunser A; Martinez P; Montaner J; Kohrmann M; Schellinger PD; Alexandrov AV; Int J Stroke; 2008 Feb; 3(1):66-72. PubMed ID: 18705918 [TBL] [Abstract][Full Text] [Related]
34. Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques. Ribo M; Alvarez-Sabín J; Montaner J; Romero F; Delgado P; Rubiera M; Delgado-Mederos R; Molina CA Stroke; 2006 Apr; 37(4):1000-4. PubMed ID: 16514102 [TBL] [Abstract][Full Text] [Related]
35. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Linfante I; Llinas RH; Selim M; Chaves C; Kumar S; Parker RA; Caplan LR; Schlaug G Stroke; 2002 Aug; 33(8):2066-71. PubMed ID: 12154264 [TBL] [Abstract][Full Text] [Related]
36. Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study. Saqqur M; Tsivgoulis G; Molina CA; Demchuk AM; Siddiqui M; Alvarez-Sabín J; Uchino K; Calleja S; Alexandrov AV; Neurology; 2008 Oct; 71(17):1304-12. PubMed ID: 18753474 [TBL] [Abstract][Full Text] [Related]
37. Treatment with tPA predicts better outcome even if MCA occlusion persists. Kablau M; Alonso A; Hennerici MG; Fatar M Int J Stroke; 2013 Oct; 8(7):496-502. PubMed ID: 22340025 [TBL] [Abstract][Full Text] [Related]
38. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke. Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399 [TBL] [Abstract][Full Text] [Related]
39. Impact of admission glucose and diabetes on recanalization and outcome after intra-arterial thrombolysis for ischaemic stroke. Arnold M; Mattle S; Galimanis A; Kappeler L; Fischer U; Jung S; De Marchis GM; Gralla J; Mono ML; Brekenfeld C; Meier N; Nedeltchev K; Schroth G; Mattle HP Int J Stroke; 2014 Dec; 9(8):985-91. PubMed ID: 22973986 [TBL] [Abstract][Full Text] [Related]
40. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Bhatia R; Hill MD; Shobha N; Menon B; Bal S; Kochar P; Watson T; Goyal M; Demchuk AM Stroke; 2010 Oct; 41(10):2254-8. PubMed ID: 20829513 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]